GlassScriptPhysician profile
Sarah Dennis Meskill
NPI 1619265386
$5,975.40
in general payments reported to CMS, 2019-2025
9 companies · $2,586 in 2025
The $2,586 reported for 2025 was more than what 96% of Pediatric Emergency Medicine (Pediatrics) providers received nationally (typical 2025 total: $53.43).
See the full distribution for Pediatric Emergency Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2022: $343 · 2023: $1,108 · 2024: $1,688 · 2025: $2,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,272 · Consulting Fee: $820 · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,272.18 |
| Consulting Fee | $820.00 |
| Education | $289.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $2,160.55 | 2023-2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $1,760.23 | 2019-2025 | |
| Harmony Biosciences LLC | $984.00 | 2022-2025 | Wakix |
| Axsome Therapeutics, INC. | $710.73 | 2022-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $250.48 | 2023-2025 | Quviviq, Quviviq |
| Lilly USA, LLC | $37.46 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $29.19 | 2023-2024 | Inspire |
| Zoll Respicardia, INC. | $22.66 | 2024 | Remede System |
| Azurity Pharmaceuticals, INC. | $20.10 | 2025 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Meskill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.